Company news

Tenaya Therapeutics, Inc. news in 2023

Tenaya Therapeutics, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Tenaya Therapeutics to Participate at the 35th Annual Piper Sandler Healthcare Conference

November 20, 2023

Tenaya Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

November 7, 2023

Tenaya Therapeutics Announces FDA Clearance to Begin Clinical Testing of TN-401 Gene Therapy for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

October 25, 2023

Tenaya Therapeutics Presents Encouraging New Clinical and Preclinical Data from HDAC6 Inhibitor Program TN-301 for the Potential Treatment of Heart Failure with Preserved Ejection Fraction at the 2023 HFSA Annual Scientific Meeting

October 8, 2023

Tenaya Therapeutics Doses First Patient in the MyPeak-1™ Phase 1b Clinical Trial of TN-201 for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy

October 4, 2023

Tenaya Therapeutics Publishes Preclinical Data in Circulation Highlighting the Clinical Potential of Cellular Reprogramming for Cardiac Regeneration

October 1, 2023

Tenaya Therapeutics to Present Data for TN-301 and TN-201 at Upcoming Medical Conferences

September 20, 2023

Tenaya Therapeutics to Participate at the 21st Annual Morgan Stanley Global Healthcare Conference

August 30, 2023

Tenaya Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

August 8, 2023

Tenaya Therapeutics to Participate at the 43rd Annual Canaccord Genuity Growth Conference

August 1, 2023

Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

May 9, 2023

Tenaya Highlights Growing Capabilities in AAV Manufacturing, Capsid Engineering and Expansion into Gene Editing with Six Abstracts Accepted for Presentation at the ASGCT 26th Annual Meeting

May 2, 2023

Tenaya Therapeutics Receives FDA Fast Track Designation for TN-201

May 1, 2023

Tenaya Therapeutics to Participate at Chardan's 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

April 20, 2023

Tenaya Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

March 7, 2023

Tenaya Therapeutics to Participate in Upcoming Investor Conferences

February 6, 2023

Tenaya Therapeutics Announces TN-201 IND Clearance and Anticipated 2023 Milestones

January 8, 2023